These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38214694)

  • 41. Relevant Physicochemical Methods to Functionalize, Purify, and Characterize Surface-Decorated Lipid-Based Nanocarriers.
    Guyon L; Groo AC; Malzert-Fréon A
    Mol Pharm; 2021 Jan; 18(1):44-64. PubMed ID: 33244972
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimal structural design of mannosylated nanocarriers for macrophage targeting.
    Chen P; Zhang X; Jia L; Prud'homme RK; Szekely Z; Sinko PJ
    J Control Release; 2014 Nov; 194():341-9. PubMed ID: 25220160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System.
    Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM
    Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Label-Free Ferrocene-Loaded Nanocarrier Engineering for In Vivo Cochlear Drug Delivery and Imaging.
    Youm I; Musazzi UM; Gratton MA; Murowchick JB; Youan BC
    J Pharm Sci; 2016 Oct; 105(10):3162-3171. PubMed ID: 27449230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nanostructured Lipid Carriers for the Delivery of Natural Bioactive Compounds.
    Shamsuddin NAM; Zulfakar MH
    Curr Drug Deliv; 2023; 20(2):127-143. PubMed ID: 35331113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nanocarrier possibilities for functional targeting of bioactive peptides and proteins: state-of-the-art.
    Moutinho CG; Matos CM; Teixeira JA; Balcão VM
    J Drug Target; 2012 Feb; 20(2):114-41. PubMed ID: 22023555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bispyrene-Based Self-Assembled Nanomaterials: In Vivo Self-Assembly, Transformation, and Biomedical Effects.
    He PP; Li XD; Wang L; Wang H
    Acc Chem Res; 2019 Feb; 52(2):367-378. PubMed ID: 30653298
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives.
    Edis Z; Wang J; Waqas MK; Ijaz M; Ijaz M
    Int J Nanomedicine; 2021; 16():1313-1330. PubMed ID: 33628022
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody-decorated chitosan-iodoacetamide-coated nanocarriers for the potential delivery of doxorubicin to breast cancer cells.
    Myat YY; Sahatsapan N; Rojanarata T; Ngawhirunpat T; Opanasopit P; Pornpitchanarong C; Patrojanasophon P
    Int J Biol Macromol; 2024 Feb; 258(Pt 1):128797. PubMed ID: 38104687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
    Noor NM; Sheikh K; Somavarapu S; Taylor KMG
    Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipid Nanoparticles and Active Natural Compounds: A Perfect Combination for Pharmaceutical Applications.
    Puglia C; Pignatello R; Fuochi V; Furneri PM; Lauro MR; Santonocito D; Cortesi R; Esposito E
    Curr Med Chem; 2019; 26(24):4681-4696. PubMed ID: 31203795
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Self-assembled nanoparticles based on galactosylated O-carboxymethyl chitosan-graft-stearic acid conjugates for delivery of doxorubicin.
    Guo H; Zhang D; Li C; Jia L; Liu G; Hao L; Zheng D; Shen J; Li T; Guo Y; Zhang Q
    Int J Pharm; 2013 Dec; 458(1):31-8. PubMed ID: 24140544
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mulberry-like dual-drug complicated nanocarriers assembled with apogossypolone amphiphilic starch micelles and doxorubicin hyaluronic acid nanoparticles for tumor combination and targeted therapy.
    Li K; Liu H; Gao W; Chen M; Zeng Y; Liu J; Xu L; Wu D
    Biomaterials; 2015 Jan; 39():131-44. PubMed ID: 25477180
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nanocrystals: A Deep Insight into Formulation Aspects, Stabilization Strategies, and Biomedical Applications.
    Purohit D; Sharma S; Lamba AK; Saini S; Minocha N; Vashist N; Kaushik D; Pandey P
    Recent Pat Nanotechnol; 2023; 17(4):307-326. PubMed ID: 35616680
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent Advances in Targeted Drug Delivery Approaches Using Lipidic and Polymeric Nanocarriers for the Management of Alzheimer's Disease.
    Jain D; Rashid MA; Ahmad FJ
    Curr Pharm Des; 2021; 27(43):4388-4403. PubMed ID: 34579627
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics.
    Datta D; Priyanka Bandi S; Colaco V; Dhas N; Siva Reddy DV; Vora LK
    Int J Pharm; 2024 Jun; 658():124192. PubMed ID: 38703931
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral drug delivery: Influence of mucus on cellular interactions and uptake of lipid-based nanocarriers in Caco-2 cells.
    Veider F; Knoll P; Jörgensen AM; Stengel D; Bernkop-Schnürch A
    Acta Biomater; 2023 Sep; 167():416-424. PubMed ID: 37311506
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Self-Assembling Drug Formulations with Tunable Permeability and Biodegradability.
    Gaynanova G; Vasileva L; Kashapov R; Kuznetsova D; Kushnazarova R; Tyryshkina A; Vasilieva E; Petrov K; Zakharova L; Sinyashin O
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Uptake Dynamics of Cubosome Nanocarriers at Bacterial Surfaces and the Routes for Cargo Internalization.
    Dyett BP; Yu H; Sarkar S; Strachan JB; Drummond CJ; Conn CE
    ACS Appl Mater Interfaces; 2021 Nov; 13(45):53530-53540. PubMed ID: 34726885
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The silibinin-loaded Zein-β cyclodextrin nano-carriers (SZBC-NCs) as a novel selective cancer cell drug delivery system in HT-29 cell line.
    Al Alabdullah MAA; Goodarzi MT; Homayouni Tabrizi M
    Sci Rep; 2024 Jun; 14(1):14769. PubMed ID: 38926533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.